Wockhardt Ltd. (WOCKPHARMA): Wockhardt Share Price Rises 2.35% to Rs 1,996.90 Today

Wockhardt Share Price was at Rs 1,996.90, up 2.35% today, with market capitalisation at Rs 30,950.7 crore. The move has put Wockhardt Ltd. back in focus on Univest as investors assess price action, valuation and the latest healthcare sector context.

Wockhardt Share Price today is trading higher after a 2.35% share price gain, with the stock last traded at Rs 1,996.90 versus the previous close of Rs 1,951.05. The company’s market capitalisation stands at Rs 30,950.7 crore, keeping Wockhardt Ltd. visible among healthcare names on the Indian stock market.

Wockhardt Share Price Today: Price Action Analysis

The latest Univest data confirms the price rise, but it does not establish a company-specific catalyst behind the move. Even so, the stock’s placement in the pharmaceuticals space, its elevated valuation multiples and its position relative to the sector benchmark make the day’s move relevant for stock analysis. For readers tracking Wockhardt Share Price Today, the key question is how much of the interest comes from price action versus fundamentals. Univest is following the same mix of market news, sector comparison and company ratios that typically shape Wockhardt Stock News.

Metric	Value
Current Price	Rs 1,996.9
Previous Close	Rs 1,951.05
Today's Move	Rs 45.85 (+2.35%)
Open	Rs 1,977.05
High	Rs 2,018
Low	Rs 1,975.25
Turnover	Rs 6.64 crore
Market Capitalisation	Rs 30,950.7 crore
Market Cap Category	Large Cap

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 1,996.9 from the previous close of Rs 1,951.05, a move of Rs 45.85 or 2.35%. The stock opened at Rs 1,977.05, reached a high of Rs 2,018, recorded a low of Rs 1,975.25.

Wockhardt Share Price today opened at Rs 1,977.05, moved between Rs 1,975.25 and Rs 2,018, and was last traded at Rs 1,996.90. The day’s gain of Rs 45.85 over the previous close of Rs 1,951.05 keeps the stock in the list of stocks rising today. Turnover was Rs 6.64 crore, which shows active interest without changing the fact that the session-level move remains the core event in Wockhardt Stock News. On Univest, this is the kind of price action that often draws attention from market movers looking for near-term stock performance signals.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 30,950.7 crore
P/E Ratio	77.51x
P/B Ratio	6.3x
ROE	4.29%
ROCE	6.79%
EPS	Rs 25.17
Book Value Per Share	Rs 309.81
Dividend Yield	0%

Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 77.51x, P/B 6.3x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.

Wockhardt Ltd. has a market capitalisation of Rs 30950.7 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 77.51x, P/B at 6.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.61x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	77.51x
Benchmark Median P/E	32.61x
Benchmark Average P/E	48.83x
Benchmark P/E Range	3.32x to 645.91x
Company P/B Ratio	6.3x
Benchmark Median P/B	2.89x
Company ROE	4.29%
Benchmark Median ROE	11.79%
Company ROCE	6.79%
Benchmark Median ROCE	13.66%
Company Market Capitalisation	Rs 30,950.7 crore
Benchmark Median Market Cap	Rs 730.27 crore

Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 77.51x, which is above the benchmark median of 32.61x, a difference of +137.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.79%, a difference of -63.61%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.66%, a difference of -50.29%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,63,791.45	37.77	5.28	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,080.59	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,90,351.29	85.89	20.87	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,832.64	25.09	4.2	19.69	21.39
Cipla Ltd.	CIPLA	1,14,162.52	33.29	3.19	11.83	16

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 77.51x compared with the displayed peer median of 37.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 30,950.7 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Wockhardt

• Wockhardt Share Price today is up 2.35%, keeping the stock on the radar of traders tracking stocks in news.
• The share price moved from Rs 1,951.05 to Rs 1,996.90, with intraday movement between Rs 1,975.25 and Rs 2,018.
• Valuation remains important, with a P/E of 77.51 and P/B of 6.3 versus the same-industry benchmark.
• ROE of 4.29% and ROCE of 6.79% are below the industry median, so fundamentals remain part of the debate.
• Market cap of Rs 30,950.7 crore keeps Wockhardt relevant within the healthcare space on Univest.

About Wockhardt

Wockhardt Ltd. is a healthcare company in the Pharmaceuticals & Drugs industry. Its business is associated with medicines and pharmaceutical products, which places Wockhardt Share Price within the broader Indian pharma universe. As a listed company on NSE and BSE, it is followed for both stock price moves and company financials. The latest Univest data shows a market capitalisation of Rs 30,950.7 crore, which gives the company a substantial size within its industry set.

For readers looking at Wockhardt Share Price Today, the key business context is not just what the company does, but how the market is pricing it. Revenue details and segment-level disclosures are not part of this article, so the focus remains on the figures that can be verified here: valuation ratios, returns and market cap. That makes Wockhardt Share Price useful for investors who want a concise company overview alongside market update coverage on Univest.

Frequently Asked Questions

Why did Wockhardt Share Price rise today?

Ans. Wockhardt Share Price rose 2.35% today, but the latest Univest figures do not establish a company-specific catalyst. The move is still important because it coincides with valuation, market cap and sector comparison that investors watch closely.

What is Wockhardt Share Price today?

Ans. Wockhardt Share Price was Rs 1,996.90, up Rs 45.85 from the previous close of Rs 1,951.05. That places the stock among the day’s notable gainers in the healthcare space.

What is the market capitalisation of Wockhardt?

Ans. Wockhardt’s market capitalisation is Rs 30,950.7 crore. This puts the company well above the same-industry median market cap of Rs 730.27 crore and above the benchmark average of Rs 14,155.46 crore.

How expensive is Wockhardt compared with pharma peers?

Ans. Wockhardt trades at a P/E of 77.51 and a P/B of 6.3. That is above several peers such as Sun Pharma, Cipla and Zydus Lifesciences, though below Divi’s Laboratories and Torrent Pharmaceuticals.

What do Wockhardt’s ROE and ROCE show?

Ans. Wockhardt’s ROE is 4.29% and ROCE is 6.79%. Both are below the same-industry median and average, which means return generation remains weaker than many healthcare peers. The relevant peer median ROE is 11.79%.

What does EPS and book value tell investors?

Ans. Wockhardt EPS is Rs 25.17 and book value per share is Rs 309.81. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

Does Wockhardt pay a dividend?

Ans. Wockhardt’s dividend yield is 0, so there is no current cash-yield angle in the latest figures. Investors are therefore likely to focus more on valuation, profitability and share price movement.

Where can I track Wockhardt Share Price live?

Ans. You can track Wockhardt Share Price on Univest for live share price updates, Wockhardt Stock News, market cap, ratios, sector context and company performance, all in one place.

Track Wockhardt Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Wockhardt Share Price on Univest for live share price updates, Wockhardt Stock News, Wockhardt Share News, valuation ratios, market cap, 52-week levels and company financials. Univest also helps readers compare Wockhardt Share Price Today with Wockhardt Stock Analysis, sector context and broader market trends in one place.